Zdrowie i gospodarka · 04/10/2000
Clinical Pharmacology During Pregnancy; Public Meeting
The Food and Drug Administration (FDA) is announcing an FDA/ National Institute for Child Health and Human Development co-sponsored meeting on "Clinical Pharmacology During Pregnancy: Addressing Clinical Needs Through Science." Experts from industry, academia, and the public have been invited to provide their perspectives on drug therapeutics during the second and third trimester of pregnancy. The goals of the meeting are: To summarize the state of knowledge regarding clinical pharmacology in pregnancy; to raise awareness among clinician researchers and leaders about the need for clinical research and collaboration in this area; and to garner support for such research from health advocacy groups and others.